Asiel Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.50 Cr
- Revenue Growth %
- Profit Growth -638.93%
- Ebitda -435.63%
- Net Worth -14.90%
- Total Assets -1.91%
About Asiel Laboratories
Asiel Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2005 and has a history of 19 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹23.50 Cr.
Hardeep Gill and Balraj Meel serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2005PTC151808
-
Company No.
151808
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Asiel Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hardeep Gill | Additional Director | 22-Aug-2024 | Current |
| Balraj Meel | Additional Director | 22-Aug-2024 | Current |
Financial Performance of Asiel Laboratories.
Asiel Laboratories Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 638.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asiel Laboratories?
In 2018, Asiel Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Fish Capital Services Private LimitedHardeep Gill and Balraj Meel are mutual person
Charges (Loans)
₹23.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 23.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2012 | State Bank Of India | ₹23.50 Cr | Open |
How Many Employees Work at Asiel Laboratories?
Unlock and access historical data on people associated with Asiel Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asiel Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asiel Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
